Search - tctmd.com

Displaying 61 - 77 of 77

Sort: Relevancy | Date

News Conference News ACC 2018

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

Michael O'Riordan

March 10, 2018

News Daily News

Increasing Total Cholesterol Less Worrisome for Cognition in Old Age

Todd Neale

March 09, 2018

News Daily News

Bempedoic Acid Phase III Trial Meets Primary Endpoint for Cutting LDL Cholesterol

Yael L. Maxwell

March 08, 2018

News Daily News

FDA: Clarithromycin Risks Persist in Patients With CAD

Todd Neale

February 26, 2018

News Daily News

Acute MI Quality Improvement Program Fails in India, but Researchers See Bright Side

L.A. McKeown

February 15, 2018

News Daily News

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

Michael O'Riordan

February 02, 2018

News Daily News

AHA Releases Scientific Statement on Breast Cancer and CVD

L.A. McKeown

February 01, 2018

News Daily News

Nonstatin Use and Expenditures Are Up Despite the Dearth of Evidence Supporting Efficacy

Yael L. Maxwell

January 29, 2018

News Daily News

Maze of Prior Authorization for PCSK9 Inhibitors Poses Challenge to Prescribers

Yael L. Maxwell

January 24, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Caitlin E. Cox

January 18, 2018

News Daily News

Bariatric Surgery: Cardiometabolic Benefits Down, but Not Out, at 5 Years

Michael O'Riordan

January 18, 2018

News Daily News

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Michael O'Riordan

January 09, 2018

News Daily News

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

Yael L. Maxwell

January 09, 2018

CME

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

CME

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

Video

» On Record

On Record: Low-Dose Statins and Antihypertensives for Intermediate Risk CVD: HOPE-3

May 11, 2018

Advertisement

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

Increasing Total Cholesterol Less Worrisome for Cognition in Old Age

Bempedoic Acid Phase III Trial Meets Primary Endpoint for Cutting LDL Cholesterol

FDA: Clarithromycin Risks Persist in Patients With CAD

Acute MI Quality Improvement Program Fails in India, but Researchers See Bright Side

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

AHA Releases Scientific Statement on Breast Cancer and CVD

Nonstatin Use and Expenditures Are Up Despite the Dearth of Evidence Supporting Efficacy

Maze of Prior Authorization for PCSK9 Inhibitors Poses Challenge to Prescribers

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Bariatric Surgery: Cardiometabolic Benefits Down, but Not Out, at 5 Years

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

On Record: Low-Dose Statins and Antihypertensives for Intermediate Risk CVD: HOPE-3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content